Alopecia is an autoimmune disorder that causes non-scarring hair loss on the scalp and body that is experienced by almost 2% ...

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...

Hair loss remains a critical issue with only a marginal rate of success. A team of researchers from Australia, Singapore, and ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

John Seymour, MBBS, FRACP, PhD, explains why BCL-2 was considered an undruggable target for so long and what led to the development of effective BCL-2 inhibitors.

The combination of the BCL-2/BCL-XL inhibitor APG-1252 with lapatinib synergistically inhibits the AKT/GSK-3β/MCL-1 signaling pathway, leading to a decrease in mitochondrial membrane potential ...